Conventional culture methods for the diagnosis of bacterial and fungal infections are often limited by a long time of culturing or the occurrence of negative results due to the administration of antibiotics or fastidious growth requirements. As an accepted alternative, culture-independent approaches are widely used.
In this webinar, Dr. Michael Lustig, COO at Molzym GmbH & Co. KG, will share his vast experience of direct molecular testing and present a wide overview of available solutions and their applications. The factors that favor direct testing will be outlined and the diagnostic value of broad-range 16S/18S rRNA gene PCR and how the results impact the antimicrobial therapy selection will also be discussed.
This webinar will cover the following:
Who should attend?
The live webinar takes place on Monday, November 16, at:
SelectScience runs 10+ webinars a month across various scientific topics, discover more of our upcoming webinars>>